✨ Don’t miss out! Discover our latest offers and exclusive deals. LEARN MORE →

Testosterone Levels in Men: What 60 Years of Data Show

Man reviewing testosterone lab results with a clinician in a comfortable consultation room

Medically reviewed by Carol Joy Bender, NP — November 18, 2026

If your feed has filled with claims that testosterone levels in men have been falling for generations, a new review gives that conversation real numbers. It also leaves an important question open: what can a population trend tell you about your own lab result? For you, the answer starts with separating two very different kinds of evidence.

The 2026 discussion of male testosterone decline is a population-level signal, not a personal diagnosis or a reason to treat one test as conclusive. The research compares averages from groups measured in different years. Your symptoms, sleep schedule, health history, medication list, assay, and collection time all shape how a clinician interprets one result.

When people compare testosterone levels in men across decades, they are comparing group averages rather than following a personal timeline. Keeping that distinction in view lets you take a large study seriously while reserving individual questions for individual testing.

Here is what the new research actually measured, where its limits sit, and what to ask for if you decide to get checked. The distinction can be especially useful if rotating shifts, deployment, or a demanding duty schedule make an ordinary morning blood draw hard to arrange.

What the 60-year review found

A systematic review and meta-regression published in World Journal of Men’s Health in 2026 included 345 studies and 169,493 men. The studies reported average total testosterone for healthy men, with a mean participant age of 37.4 years and mean body mass index of 24.0. Instead of following the same men over six decades, the authors compared study-level averages across birth cohorts and publication periods.

The review found a downward association across successive birth cohorts. When the authors compared study averages from the 1960s with those from the 2020s, total testosterone was 22.1% lower among men younger than 30, 28.2% lower among men 30 to 40, and 17.2% lower among men 40 and older. The comparison uses different studies and participants at each end of the timeline, not paired blood samples from the same men.

In its age subgroup analysis, the estimated slope was about 3.55 ng/dL lower per year among men younger than 30, with a 95% confidence interval from 1.53 to 5.56 ng/dL lower. For men 30 to 40, the estimated decline was about 2.95 ng/dL per year. Among men 40 and older, the slope was smaller and the confidence interval included no change. These are estimates from a broad evidence synthesis, not a forecast for any one person’s future test.

The authors also reported a steeper association among men classified as normal weight than among men with overweight or obesity. That pattern is worth noticing because it complicates the simple story that increasing body weight explains every reported change. It still cannot identify a cause. Study-level comparisons cannot show whether an exposure, a measurement change, a shift in who volunteered for research, or another factor produced the difference.

There are other limits. The review combined studies that were not designed as one continuous surveillance project, and the included studies varied in population, assay, sampling practice, and calendar period. The paper’s title uses the word accelerating, but a meta-regression of published averages cannot establish what caused a trend or prove that it will continue at the same rate. The authors reported no funding and no conflicts of interest.

That is why the most accurate reading is narrower than a viral headline. The review identifies a possible population-level shift in reported averages and a stronger signal in younger study groups. It does not show that every man has lower testosterone than his father, that a particular lifestyle caused the difference, or that an individual with a normal result should expect a future problem. You can read the 2026 World Journal of Men’s Health review for the full methods and subgroup estimates.

A Korean cohort adds a different view

A separate nationwide study looked at age rather than successive generations. Researchers reviewed morning test results from 27,687 men aged 40 and older who had routine health examinations at 20 hospitals across South Korea between 2015 and 2024. The mean result was 4.8 ng/mL, equivalent to 480 ng/dL, and the study reported an average decrease of about 2.1 ng/dL for each additional year of age.

The proportion below that study’s biochemical cutoff of 250 ng/dL rose from 5.5% among men aged 40 to 49 to 11.6% among those 70 and older. Higher body mass index, fasting glucose, and triglycerides were associated with lower measured testosterone in adjusted analyses. Those associations do not establish which factor came first or whether changing one would change a person’s hormone result.

The Korean analysis was cross-sectional, meaning it compared different men in age groups rather than repeatedly measuring the same men as they aged. It also lacked symptom-based assessment and did not confirm a clinical diagnosis. The authors noted that lifestyle information such as smoking, alcohol use, activity, and diet was unavailable. The study received a 2023 research grant from Gyeongsang National University, and its authors reported nothing to disclose. The South Korean study is useful regional evidence, but its results should be read within those limits.

These two papers answer different questions. The global review asks whether average measurements differ across birth cohorts; the Korean study asks how results vary by age within a decade of health examinations. Age-related change and a possible generational shift can coexist, but neither study tracks an individual man’s lifetime trajectory.

A population average is not your lab result

When you see a number on a lab report, the first useful question is which reference interval and assay produced it. A 2017 study harmonized measurements from four United States and European cohort studies involving 9,054 community-dwelling men. In a CDC-tested subset of 400 samples, the researchers adjusted cohort values to a common method. For healthy, nonobese men aged 19 to 39, the resulting 2.5th-to-97.5th percentile range was 264 to 916 ng/dL. Testosterone reference ranges describe a distribution in a defined group, not a personalized target.

That interval describes the distribution in a defined group. It is not a universal treatment threshold, a target every man should reach, or an age-adjusted range for every adult. In the same harmonized data, the 5th percentile was 303 ng/dL. The gap between 264 and 303 shows why a lab’s lower limit, a guideline cutoff, and a clinician’s diagnosis are related ideas rather than interchangeable labels. The original harmonized reference-range study also found that assay differences explained a substantial share of variation between cohorts.

Guidelines set cutoffs for a clinical decision, while reference intervals describe a measured distribution. The Endocrine Society’s 2026 statement says diagnosis should combine compatible symptoms with consistently low, accurately measured results and describes a common clinical threshold near 300 ng/dL. It recommends at least two early-morning, fasting tests and stresses the value of standardized assays. The statement reserves testing for men with symptoms or clinical indications rather than recommending a population-wide screen.

European guidance frames the threshold differently. The European Association of Urology’s 2026 summary recommends morning testing between 7 and 10 after fasting and gives 12 nmol/L, approximately 346 ng/dL, as a threshold for symptomatic men in clinical practice. A cutoff is one part of an evaluation, not a self-diagnosis shortcut. The two guidance documents also differ in how their thresholds are presented, so the appropriate interpretation depends on the guideline, clinical context, assay, and symptoms.

That context matters if your result is near a lower limit or conflicts with how you feel. The EAU summary says a clinician may review sex hormone-binding globulin and calculated free testosterone when altered binding-protein levels could change how total testosterone reads. It also notes that evidence supporting broader use of calculated free testosterone remains limited. Those additions answer a clinical question; they are not a checklist that every man needs automatically.

Shift work changes when a test makes sense

Most standard guidance describes a morning blood draw, often after fasting, because testosterone measurements can vary with sleep and time of collection. For a rotating-shift paramedic, firefighter, or service member on an irregular schedule, clock time may not match biological morning. A draw after a disrupted sleep period can be harder to compare with a properly rested sample, so tell the clinician when you usually sleep and wake before setting the appointment.

A small laboratory study published in the Journal of the Endocrine Society in 2022 helps explain the issue. Fourteen healthy adults completed three days of simulated night-shift or day-shift schedules, followed by a controlled 24-hour observation; only 10 participants were men. Testosterone itself did not show a clear endogenous circadian rhythm in that experiment. The authors suggested that the sleep-wake pattern and other behaviors may help explain patterns seen in ordinary testing, and recommended testing shift workers soon after waking rather than relying on a fixed clock time.

That is a practical hypothesis, not a settled protocol for every occupation. Participants were healthy adults with no recent shift-work exposure. The simulated night schedule lasted three days, so longer-term adaptation among rotating-shift workers remains an open question. The study’s funding included university, National Institutes of Health, Veterans Affairs, and Army Medical Research awards. Two authors disclosed industry consulting or research relationships unrelated to this study. The simulated-shift study gives clinicians a reason to ask about sleep timing, while its small size leaves room for better real-world research.

If you are currently on night shift or returning from deployment, say so plainly when you schedule the blood draw. Record your usual sleep window, the time you woke, and whether illness, a major schedule change, or a medication change occurred around the test. Those details help the clinician interpret a result in the conditions that shaped it.

What to ask for before you act on a number

Clinician pointing to a male hormone testing panel on a clipboard during a consultation

If you and your clinician decide that testing fits your symptoms, focus first on whether the sample can be interpreted. Ask about the assay used, how the lab defines its reference interval, and whether a repeat measurement is appropriate. A single low result after poor sleep or during an acute illness may need a different conversation from two consistent measurements collected under comparable conditions.

Bring a short account of the changes that led you to ask. Reduced sexual interest, low energy, and mood shifts can each have several causes, as the Endocrine Society statement notes. The same statement identifies obesity and medications such as corticosteroids or opioids as contributors a provider may review. If you work rotating shifts or have a military schedule, include your usual sleep window and recent changes to it. Naming a symptom is not an admission of weakness, and seeking a private medical assessment is separate from deciding what information belongs in a duty-status process.

These are useful questions to take into the appointment:

  • Was the total testosterone assay standardized or CDC HoST-certified, and how does this lab set its lower reference limit?
  • Should the result be repeated under similar conditions, with collection timed to my main sleep period if I work nights?
  • Given my symptoms and total result, would sex hormone-binding globulin or calculated free testosterone clarify the picture?

Those questions are more useful than asking for a number to be pushed higher. If the result is repeatedly low, the next step is to understand why and whether the finding fits your symptoms. If the result is within range, a clinician can still help look for other contributors to the change you noticed. For a broader overview of what labs can and cannot tell you, see JWP’s guide to common blood tests. If you want background on a separate conversation about testosterone services, read JWP’s overview of testosterone therapy for men.

What the trend can tell you

The 2026 review identifies a large population question; its methods leave causes unresolved and cannot predict your personal result. A careful approach to testosterone levels in men starts with symptoms, repeatable measurements, assay quality, and the details of your sleep and work schedule.

Testosterone testing is most informative when the number is interpreted in the context that produced it.

Smiling Joy Wellness Partners clinician in navy scrubs standing outdoors

If you have questions about symptoms or a recent result, bring the report and your usual sleep schedule to a clinician. Joy Wellness Partners can help you review the information and decide what questions to take into a consultation. You can book a consultation with the clinic to discuss what testing may fit your situation.

Sources

Disclaimer: This article is for general educational purposes only and is not medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider about your personal health situation.

Featured Articles

Contact Us

Choose Your Location